Exclusive: Germany OKs Northwest Bio brain cancer drug, shares soar

(Reuters) – Germany has granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug in the country, the company said, and its stock jumped as much as 36…

    

Leave a Reply

Your email address will not be published.